- Home
- IZTC vs RANI Comparison
IZTC vs RANI Comparison
Compare IZTC & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZTC
- RANI
- Stock Information
- Founded
- IZTC 2019
- RANI 2012
- Country
- IZTC United States
- RANI United States
- Employees
- IZTC N/A
- RANI N/A
- Industry
- IZTC Biotechnology: Biological Products (No Diagnostic Substances)
- RANI Medicinal Chemicals and Botanical Products
- Sector
- IZTC Health Care
- RANI Health Care
- Exchange
- IZTC Nasdaq
- RANI Nasdaq
- Market Cap
- IZTC 69.5M
- RANI 73.8M
- IPO Year
- IZTC 2024
- RANI 2021
- Fundamental
- Price
- IZTC N/A
- RANI $2.27
- Analyst Decision
- IZTC
- RANI Strong Buy
- Analyst Count
- IZTC 0
- RANI 5
- Target Price
- IZTC N/A
- RANI $11.80
- AVG Volume (30 Days)
- IZTC 48.5K
- RANI 762.4K
- Earning Date
- IZTC 01-01-0001
- RANI 11-14-2024
- Dividend Yield
- IZTC N/A
- RANI N/A
- EPS Growth
- IZTC N/A
- RANI N/A
- EPS
- IZTC N/A
- RANI N/A
- Revenue
- IZTC N/A
- RANI N/A
- Revenue This Year
- IZTC N/A
- RANI N/A
- Revenue Next Year
- IZTC N/A
- RANI N/A
- P/E Ratio
- IZTC N/A
- RANI N/A
- Revenue Growth
- IZTC 145.01
- RANI N/A
- 52 Week Low
- IZTC $8.50
- RANI $1.90
- 52 Week High
- IZTC $12.00
- RANI $8.75
- Technical
- Relative Strength Index (RSI)
- IZTC N/A
- RANI 44.83
- Support Level
- IZTC N/A
- RANI $2.32
- Resistance Level
- IZTC N/A
- RANI $2.67
- Average True Range (ATR)
- IZTC 0.00
- RANI 0.16
- MACD
- IZTC 0.00
- RANI -0.01
- Stochastic Oscillator
- IZTC 0.00
- RANI 11.11
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.